Abstract
This caregiver perspective article shares a decades-long experience of a family navigating the health system to obtain an accurate diagnosis for their nonbinary child, ultimately identified with Hypermobile Ehlers-Danlos Syndrome (hEDS) with Median Arcuate Ligament Syndrome (MALS), and Tethered Cord Syndrome. As a health communications professional, the author describes how symptoms were repeatedly dismissed or misdiagnosed, highlighting the systemic challenges in listening and collaboration, as well as including the patient voice in the diagnostic process. The article offers practical recommendations rooted in lived experience to inform health providers, innovators and policymakers that listening is not a courtesy — it is a clinical necessity.
Introduction
In health, we often say, “When you hear hoofbeats, think horses, not zebras.” But sometimes, the patient is the zebra.
This article shares the caregiver perspective of parents with extensive health sector experience, steeped in health industry dynamics, who thought they understood the health system. Over nearly three decades, this child suffered symptoms that defied diagnosis—symptoms physicians dismissed, misunderstood, or treated piecemeal. The consequences were physical, emotional and lasting.
This family's story illustrates what happens when the health system is not built to connect clinical dots. The article offers reflections from the caregiver's point of view and outlines actionable recommendations for how health systems can better respond to patients with rare, complex, or misunderstood conditions. Healing begins with the right clinical tools, curiosity, compassion, and collaborative care.
Personal Perspective
This young person was always active, unusually brilliant and empathetic. But by early adolescence, something changed. They experienced severe stomach pain, fatigue, joint hypermobility, migraines, and fainting spells. They saw pediatricians, neurologists, rheumatologists, cardiologists. Each one focused on a body part—none stepped back to view the whole (person) picture. One treated them for Lyme disease for nearly a year without considering other causes. Another thought was that it was solely mental health—“in their head.” The “zebra” baffled physicians, and, faced with complexity, they often retreated.
The turning point came during college, when the student interned at the Marfan Foundation one summer. Marfan is a connective tissue condition related to other illnesses. A staff member gently suggested Ehlers-Danlos syndrome (EDS) might explain the complexity of symptoms. A referral to a cardiologist at NYU Langone led to an experiential breakthrough. That clinician didn’t dismiss or rush. She said, “I don’t know what this is, but we’ll get to the bottom of it.” That thorough diagnostic workup eventually led to the first key diagnosis: hEDS.
Around the same time, the patient did what many people do—they entered their symptoms into Google. Surprisingly, in a pre-AI world, “Dr Google's” top results pointed toward EDS. It was a digital clue, a breadcrumb of truth, discovered not in a textbook but through a patient's search—a precursor to today's AI-assisted diagnostics. While AI will never replace the power of human empathy, it has the potential to rally health professionals to bench test hypotheses, explore emerging patterns, and revisit assumptions. Rather than defaulting to the most convenient conclusion, digital tools can prompt deeper curiosity, especially when guided by a patient's experience.
EDS is a connective tissue disorder with 13 recognized subtypes, ranging from the more common hypermobile form to the rare, life-threatening vascular subtype. 1 Each type carries a distinct constellation of symptoms and risks. Some people face chronic dislocations and mobility challenges, while others live with the daily fear of spontaneous organ rupture.
The pains persisted—joints, migraine and stomach. The patient was unable to keep food down. Weight dropped. An ER visit almost ended in discharge until a family member insisted, with a supportive on-call GI, on an upper GI scan. That test revealed severe constipation linked to extreme low motility—something missed by others—and a common symptom of hEDS.
The search continued. A GI consult in New York ended when a prominent robotic surgeon dismissed the mention of a patient advocate's input. “Who will you believe—me or a patient?” he asked. The physician's reaction underscored how patient voices are often viewed as unwelcome and that a white coat and stethoscope can evolve into a license to dismiss patient input.
A second clinical opinion in California confirmed what had been overlooked: MALS syndrome. The day after surgery, the patient was able to eat without pain. A significant barrier had been lifted.
But the journey wasn’t over. Weakness, leg pain and numbness worsened. They began using a walker, then a wheelchair. Another diagnosis emerged: Tethered Cord Syndrome. Complex spinal surgery provided answers and relief, but it raised more questions: why had this taken so long to uncover?
Today, the patient carries the trauma of years spent unheard. Medical-system PTSD is real. Even scheduling appointments ignites anxiety. They hold no resentment toward clinicians—many work in a system designed for speed and institutional survival, not patient complexity. Still, speed should never override listening. The pain of dismissal often cuts deeper than the condition itself.
But what of the trauma of thousands of patients and health professionals facing similar dilemmas every day? The US health system does not lack innovation, financial investment, or good intentions. The system's challenge isn’t material—it is mindset. Listening and validating the patient's real-world experience is an essential—too often overlooked skill—part of a thorough intake and necessary for therapeutic decision making.
Practical Recommendations
Empower Caregiver and Patient Voices: Caregivers and patients are the best historians of a clinical journey. They connect the dots. They share their symptoms and self-directed hypotheses. Providers must engage them as allies, not afterthoughts. Not a people who “they do stuff to,” but instead who work as a team.
Train for Diagnostic Curiosity: Rare conditions mimic common ones. Teach clinicians to say, “I don’t know—but I’ll stay with you until we find out.” Curiosity is a clinical competency.
Incentivize Collaboration: Siloed care causes harm. Interdisciplinary case reviews should be built into the system, especially for complex patients. Technology must be used to bridge silos, not deepen them.
Reduce Insurance Barriers: Coverage hurdles delay testing and referrals. Systems must align financial approval with a higher understanding that people who pay for insurance are more than “beneficiaries” of services; they are customers.
Use Real-world evidence (RWE): RWE is more than a repository of outcomes—it is a testament to the value of listening to patients and caregivers. These insights can validate treatments, inform diagnostics, and accelerate recognition of rare diseases.
Center Empathy in Training: Dismissiveness isn’t benign; it adds to the pain. Select and train health professionals to listen with intention and reflect on what they hear. Empathy will improve outcomes.
These are not radical suggestions—they’re the foundation for treating people, not just symptoms.
Conclusion
This caregiver's story is not unique. Behind every delayed diagnosis is a person, sometimes a child, overcoming a condition and, too often, a system that doesn’t believe them. Payers should realize that early, accurate diagnosis leads to faster, more cost-effective care.
Let's shift from a model that prioritizes efficiency over empathy. Let's slow down to hear the story before making the clinical call. Listening isn’t extra. It's essential.
As a dedicated health communicator, I see patients learning to navigate the system, their exhaustion, and their ongoing struggle. I now share this story as one of many: The best care results from clinicians who don’t just look but see. Don’t just hear—but listen. This is not just advice to providers but also to payers, policymakers, and product innovators.
Footnotes
Acknowledgments
This editorial article reflects the personal perspectives of the author.
Declaration of Conflicting Interests
The author declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding
The author received no financial support for the research, authorship, and/or publication of this article.
